Catalyst Wire Dossier Catalyst Wire Dossier

Tesmilifene (YMB1002)

tesmilifene · YM BioSciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tesmilifene (YMB1002), covering 2014-04-21 to 2014-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer [Phase 1]

See pricing